Antiangiogenic therapy exerts antitumor effects by altering the tumor microenvironment: bibliometric analysis

Yuan Kang1, Yixin Kang1, Dianbao Zhang1

  • 1The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.

Frontiers in Immunology
|December 18, 2024
PubMed
Abstract

Insights

Antiangiogenic therapy impacts the tumor microenvironment (TME) to fight cancer. This bibliometric analysis reveals research trends and collaboration gaps in antiangiogenic therapy and TME interactions.

Area of Science:

  • Oncology
  • Cancer Research
  • Immunotherapy

Background:

  • Antiangiogenic therapy modulates the tumor microenvironment (TME), offering anti-tumor effects.
  • It holds potential for enhancing conventional and immunotherapy efficacy.
  • Understanding the antiangiogenic therapy-TME relationship is crucial for cancer treatment advancement.

Purpose of the Study:

  • To conduct a bibliometric analysis of research on antiangiogenic therapies and the TME.
  • To identify current research hotspots and collaborative networks in this field.
  • To provide insights for future research directions and facilitate scientific exchange.

Main Methods:

  • Bibliometric analysis of publications from the Web of Science Core Collection (inception-December 2023).
  • Utilized Bibliometrix packages in R for in-depth analysis.
  • Employed VOSviewers and Citespace for keyword and collaborative network analysis.

Main Results:

  • A total of 9027 publications were analyzed, originating from 27 countries and 1387 journals.
  • Research output surged from 2014-2023 (73.87%), with China leading in publications.
  • Key research shifts include focus on vascular endothelial growth factor, antivascular therapy, nanoparticle delivery systems, and immunotherapy.

Conclusions:

  • The field of antiangiogenic therapy and TME interactions is rapidly evolving.
  • Limited international and institutional collaboration exists.
  • This study offers insights into research trends, hotspots, and collaboration opportunities to advance the field.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K